Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
Items 201–300 of 931
CDK inhibitor Palbociclib targets STING to alleviate autoinflammation
Gao, J., Zheng, M., Wu, X., Zhang, H., Su, H., Dang, Y., Ma, M., Wang, F., Xu, J., Chen, L., et al. (2022) · EMBO Reports · doi:10.15252/embr.202153932 · Cited by 69
“…leads to inefficient degradation of self-DNA and subsequent aberrant activation of the cGAS-STING pathway with hyperproduction of chemokines and cytokines, leading to tissue damage in the scenario of SLE and AGS (Liu et al , 2014; Crow & Manel, 2015; Rice et al , 2015; McCauley et al , 2020).”
Aicardi–Goutières syndrome: A monogenic type I interferonopathy
Liu, A., & Ying, S. (2023) · Scandinavian Journal of Immunology · doi:10.1111/sji.13314 · Cited by 79
Brain organoids as a model system for human neurodevelopment and disease
Setia, H., & Muotri, A. R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.03.002 · Cited by 72
Type I interferon–related kidney disorders
Lodi, L., Mastrolia, M. V., Bello, F., Rossi, G. M., Angelotti, M. L., Crow, Y. J., Romagnani, P., & Vaglio, A. (2022) · Kidney International · doi:10.1016/j.kint.2022.02.031 · Cited by 71
Self-citationType I interferon dysregulation and neurological disease
McGlasson, S. L., Jury, A., Jackson, A. P., & Hunt, D. P. J. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.143 · Cited by 62
B-cell tolerance and autoimmunity
Tsubata, T., & Honjo, T. (2017) · F1000Research · doi:10.12688/f1000research.10583.1 · Cited by 79
Neuroimmune disorders of the central nervous system in children in the molecular era
Wells, E. M., Hacohen, Y., Waldman, A. T., Tillema, J. M., Soldatos, A. G., Ances, B. M., Benseler, S. M., Bielekova, B., Dale, R. C., Dalmau, J. O., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0024-9 · Cited by 72
Immune Responses to Retroviruses
Sáez‐Cirión, A., & Manel, N. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052155 · Cited by 71
Self-citationProtective and Pathogenic Effects of Interferon Signaling During Pregnancy
Casazza, R. L., Lazear, H. M., & Miner, J. J. (2019) · Viral Immunology · doi:10.1089/vim.2019.0076 · Cited by 62
“However, in an animal model of SAVI (heterozygous STING N153S knockin mice), disease is associated with lethality in pregnant dams and upregulation of ISGs in adult mice, although the mechanism of impaired survival during pregnancy was not determined (111).”
InfluentialStorci, G., Carolis, S. D., Papi, A., Bacalini, M. G., Gensous, N., Marasco, E., Tesei, A., Fabbri, F., Arienti, C., Zanoni, M., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-018-0255-8 · Cited by 69
Microglial responses to peripheral type 1 interferon
Aw, E., Zhang, Y., & Carroll, M. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02003-z · Cited by 62
“Abbreviations AGS: Aicardi-Goutières syndrome; BBB: Blood-brain barrier; CNS: Central nervous system; DE: Differentially expressed; GO: Gene ontology; IFNα: Interferon alpha; IFNγ: Interferon gamma; mIFNα: Murine interferon alpha; IFNAR: Type 1 interferon receptor; IL-1β: Interleukin 1 beta; IL6: Interleukin 6; IRF9:…”
BackgroundInfluentialFernández, D., & Kirou, K. A. (2016) · Current Rheumatology Reports · doi:10.1007/s11926-016-0562-3 · Cited by 75
Decoding inflammation, its causes, genomic responses, and emerging countermeasures
Hawiger, J., & Zienkiewicz, J. (2019) · Scandinavian Journal of Immunology · doi:10.1111/sji.12812 · Cited by 67
Hamilton, N., Rutherford, H. A., Petts, J. J., Isles, H. M., Weber, T., Henneke, M., Gärtner, J., Dunning, M. J., & Renshaw, S. A. (2020) · Glia · doi:10.1002/glia.23829 · Cited by 62
“The phenotype of another common leukodystrophy, Aicardi Goutières Syndrome (AGS), resembled a cytomegalovirus brain infection with early upregulation of type I interferon being central to the pathology (Crow & Manel, 2015).”
BackgroundTan, J., Wu, B., Chen, T., Chen, F., Zhao, J., Xiong, C., Feng, C., Xiao, R., Ding, C., Tang, W., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00398 · Cited by 62
cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases
Chen, K., Lai, C., Su, Y., Bao, W. D., Yang, L. N., Xu, P.-P., & Zhu, L.-Q. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210924110144 · Cited by 66
“AD = Alzheimer’s disease AGS = Aicardi-Goutières Syndrome ALS = Amyotrophic Lateral Sclerosis Aβ = Amyloid-beta BBI = Bowman-Birk Inhibitor CAG = Cytosine-adenine-guanine cGAMP = Cyclic Guanosine Monophosphate-adenosine Monophosphate cGAS = Cyclic Guanosine Monophosphate-adenosine Monophosphate Synthase CNS = Central…”
BackgroundActivation of STING Based on Its Structural Features
Hussain, B., Xie, Y., Jabeen, U., Lu, D., Yang, B., Wu, C., & Shang, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.808607 · Cited by 63
“However, if STING is activated in an uncontrolled manner, it will cause autoimmune diseases such as Aicardi– Goutieres syndrome (AGS) (29) and STING-associated vasculopathy with onset in infancy (SAVI) (30).”
BackgroundLoss of function of CMPK2 causes mitochondria deficiency and brain calcification
Zhao, M., Su, H., Zeng, Y., Sun, Y., Guo, X.-X., Li, Y., Wang, C., Zhao, Z., Xue-jing, H., Lin, K.-J., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00475-2 · Cited by 68
Microglial Interferon Signaling and White Matter
McDonough, A., Lee, R. V., & Weinstein, J. R. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2307-8 · Cited by 60
Meesilpavikkai, K., Dik, W. A., Schrijver, B., van Helden-Meeuwsen, C. G., Versnel, M. A., van Hagen, P. M., Bijlsma, E. K., Ruivenkamp, C. A. L., Oele, M. J., & Dalm, V. A. S. H. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40805 · Cited by 61
“Familial Aicardi- Goutieres syndrome due to SAMHD1 mutations is associated with chronic arthropathy and contractures.”
BackgroundInfluentialSwitching Sides: How Endogenous Retroviruses Protect Us from Viral Infections
Badarinarayan, S. S., & Sauter, D. (2021) · Journal of Virology · doi:10.1128/jvi.02299-20 · Cited by 71
“For example, patients suffering from Aicardi-Goutières syndrome (AGS) show aberrant immune activation and lack cellular factors such as SAMHD1 or TREX1 that reduce the levels of endogenous retroviral RNA/DNA species (24).”
BackgroundADAR1 , inosine and the immune sensing system: distinguishing self from non‐self
Liddicoat, B., Chalk, A. M., & Walkley, C. R. (2015) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1322 · Cited by 69
“AGS is a rare autoimmune disorder with a number of different genetic causes identified, yet all are characterized by an elevated type-I interferon signature.(75) The identification of AGS patients with ADAR1 mutations further reinforced the concept that notwithstanding the vastly different number of editing sites betw…”
BackgroundRINCK-mediated monoubiquitination of cGAS promotes antiviral innate immune responses
Liu, Z.-S., Zhang, Z., Cai, H., Zhao, M., Mao, J., Dai, J., Xia, T., Zhang, X., & Li, T. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0233-3 · Cited by 64
Abasic and oxidized ribonucleotides embedded in DNA are processed by human APE1 and not by RNase H2
Malfatti, M. C., Balachander, S., Antoniali, G., Koh, K. D., Saint-Pierre, C., Gasparutto, D., Chon, H., Crouch, R. J., Storici, F., & Tell, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx723 · Cited by 59
SAMHD1 and the innate immune response to cytosolic DNA during DNA replication
Coquel, F., Neumayer, C., Lin, Y., & Pasero, P. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.017 · Cited by 66
Willemsen, J., Wicht, O., Wolanski, J., Baur, N., Bastian, S., Haas, D. A., Matula, P., Knapp, B. L., Meyniel‐Schicklin, L., Wang, C., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.021 · Cited by 63
Orvain, C., Lin, Y., Jean‐Louis, F., Hocini, H., Hersant, B., Bennasser, Y., Ortonne, N., Hotz, C., Wolkenstein, P., Boniotto, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131180 · Cited by 62
“Coquel F, et al. SAMHD1 acts at stalled replication forks to prevent interferon induction.”
BackgroundInfluentialSTING Agonists/Antagonists: Their Potential as Therapeutics and Future Developments
Guerini, D. (2022) · Cells · doi:10.3390/cells11071159 · Cited by 58
“A similar mechanism is common to AGS patients, who have mutations in other DNA processing enzymes (RNASEH2A, RNASEH2B, RNASEH2C, and SAMHD1) [9].”
BackgroundThe role of cGAS in innate immunity and beyond
Ablasser, A., & Gulen, M. F. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1423-2 · Cited by 59
“In humans, mutations within TREX1 are associated with AicardiGoutières syndrome (AGS), chilblain lupus, and systemic lupus erythematodes (SLE) suggesting that cGAS may be a critical component for the development of these particular human autoimmune syndromes [55].”
BackgroundSAMHD1 Suppression of Antiviral Immune Responses
Chen, S., Bonifati, S., Qin, Z., Gelais, C. S., & Wu, L. J. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.09.009 · Cited by 55
Therapeutic Targeting of RIG-I and MDA5 Might Not Lead to the Same Rome
Kasumba, D. M., & Grandvaux, N. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.003 · Cited by 61
“Other relevant signs and symptoms include brain atrophy and increased levels of type I interferon (IFN-I) in the CSF, as well as abnormal enlargement of the liver and skin lesions [87].”
BackgroundMustelin, T., & Ukadike, K. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.593891 · Cited by 60
SUMO2 and SUMO3 redundantly prevent a noncanonical type I interferon response
Crowl, J. T., & Stetson, D. B. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802114115 · Cited by 58
“Moreover, numerous other monogenic autoinflammatory diseases are characterized by a type I IFN signature that can be identified in peripheral blood cells, collectively referred to as “interferonopathies” (8).”
BackgroundMechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2)
Lee, P. Y., Aksentijevich, I. A., & Zhou, Q. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00918-8 · Cited by 58
“Autoinflammatory conditions with over-activation of IFN-I, broadly known as primary interferonopathies, include a wide clinical spectrum of clinical features including small vessel vasculitis, brain calcification, interstitial lung disease, and autoantibody production among a plethora of autoimmune manifestations [64].”
BackgroundMlčochová, P., Caswell, S. J., Taylor, I. A., Towers, G. J., & Gupta, R. K. (2017) · The EMBO Journal · doi:10.15252/embj.201796880 · Cited by 59
“As SAMHD1 was shown to mediate spontaneous expression and release of IFN when mutated (Crow & Manel, 2015) or deleted (Behrendt et al, 2013), we investigated the possibility that DNA damage induction could activate a type I IFN response and block HIV-1 infection in MDM.”
BackgroundGain-of-function CEBPE mutation causes noncanonical autoinflammatory inflammasomopathy
Göös, H., Fogarty, C. L., Sahu, B., Plagnol, V., Rajamäki, K., Nurmi, K., Liu, X., Einarsdóttir, E., Jouppila, A., Pettersson, T., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.06.003 · Cited by 60
Wang, X., Wang, Y., Cao, A., Luo, Q., Chen, D., Zhao, W., Xu, J., Li, Q., Bu, X., & Quan, J. (2023) · Nature Communications · doi:10.1038/s41467-023-41892-5 · Cited by 60
“degrading cytosolicDNA, leadto the accumulation of cytosolic dsDNA and aberrant activation of cGAS-STING pathway, subsequently trigger autoimmune diseases 25,26 , such as Aicardi-Goutières syndrome (AGS) 27,28 or chilblain lupus 29 and systemic lupus erythematosus (SLE) 30,31 .”
Filament assemblies in foreign nucleic acid sensors
Sohn, J., & Hur, S. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.01.011 · Cited by 54
Interferons Induce Expression of SAMHD1 in Monocytes through Down-regulation of miR-181a and miR-30a
Rieß, M., Fuchs, N. V., Idica, A., Hamdorf, M., Flory, E., Pedersen, I. M., & König, R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752584 · Cited by 77
“It was suggested that SAMHD1 prevents the accumulation and sensing of endogenous nucleic acid species that would otherwise lead to induction of interferon (IFN) (11, 13).”
BackgroundAdenosine-to-Inosine RNA Editing in Health and Disease
Gatsiou, A., Vlachogiannis, N. I., Lunella, F. F., Sachse, M., & Stellos, K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7295 · Cited by 57
“(28, 29)].”
Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 Patients
Mutairi, F. A., Alfadhel, M., Nashabat, M., El‐Hattab, A. W., Ben‐Omran, T., Hertecant, J., Eyaid, W., Ali, R., AlAsmari, A. M., Kara, M., et al. (2017) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2017.09.002 · Cited by 58
SAMHD1: Recurring roles in cell cycle, viral restriction, cancer, and innate immunity
Mauney, C. H., & Hollis, T. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1454912 · Cited by 64
Lin, B., & Goldbach‐Mansky, R. T. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.10.027 · Cited by 60
Gu, L., Casserly, D., Brady, G., Carpenter, S. B., Bracken, A. P., Fitzgerald, K. A., Unterholzner, L., & Bowie, A. (2022) · Nature Communications · doi:10.1038/s41467-021-27701-x · Cited by 54
Dermatologic Manifestations of Monogenic Autoinflammatory Diseases
Shwin, K., Lee, C. R., & Goldbach‐Mansky, R. T. (2016) · Dermatologic Clinics · doi:10.1016/j.det.2016.07.005 · Cited by 53
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript HA20 Haploinsufficiency of A20 HIDS Hyperimmunoglobulinemia D and periodic fever syndrome IL-1 Interleukin-1 IFN Interferon Ig Immunoglobulin JMP Joint contractures, muscle atrophy, microcytic anemia and panniculitisinduced lipodystrophy L…”
BackgroundInfluentialDermatologic and Dermatopathologic Features of Monogenic Autoinflammatory Diseases
Figueras‐Nart, I., Mascaró, J. M., Solanich, X., & Hernández‐Rodríguez, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02448 · Cited by 70
“Dermatologic manifestations Skin involvement comprises chilblain lesions on the feet, hands, and ears, digital vasculitis, generalized skinmottling, lipoatrophy, panniculitis, and acral necrotic lesions (14, 156, 160).”
BackgroundInfluentialThe role of cGAS/STING in intestinal immunity
Wottawa, F., Bordoni, D., Baran, N., Rosenstiel, P. C., & Aden, K. (2021) · European Journal of Immunology · doi:10.1002/eji.202048777 · Cited by 57
Park, K., Ryoo, J., Jeong, H., Kim, M., Lee, S., Hwang, S.-Y., Ahn, J., Kim, D., Moon, H. C., Baek, D., et al. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009523 · Cited by 54
Ain, Q., Schmeer, C., Wengerodt, D., Witte, O. W., & Kretz, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072477 · Cited by 52
“Of note, several gene mutations driving impairments in the metabolism of nucleic acids, including the processing and degradation of cytosolic DNAs and DNA:RNA hybrids derived from TEs, can elicit a corresponding interferon-mediated inflammatory syndrome in humans in the form of Aicardi-Goutières syndrome, an inherited…”
BackgroundLi, X., Zhou, Y., Fang, Q., Yang, M., Huang, J., Li, Z., Wang, J., & Chen, T. (2022) · Science Advances · doi:10.1126/sciadv.abh0496 · Cited by 62
“…mice containing N153S or V154M mutations of murine STING demonstrated severe perivascular inflammation in the lung and skin, which may be caused by myeloid cell expansion, T cell cytopenia, and disruption of lymph node organogenesis and innate lymphoid cell development ( 2 – 5 , 13 , 53 – 58 ).”
InfluentialThe immune modules conserved across the tree of life: Towards a definition of ancestral immunity
Bernheim, A. G., Cury, J., & Poirier, E. Z. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002717 · Cited by 60
Adenosine-to-inosine RNA editing in the immune system: friend or foe?
Nakahama, T., & Kawahara, Y. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03466-2 · Cited by 55
Huffman, B. J., Chen, S., Schwarz, J. L., Plata, R. E., Chin, E. N., Lairson, L. L., Houk, K. N., & Shenvi, R. A. (2020) · Nature Chemistry · doi:10.1038/s41557-019-0413-8 · Cited by 52
Regulation and inhibition of the DNA sensor cGAS
Hertzog, J., & Rehwinkel, J. (2020) · EMBO Reports · doi:10.15252/embr.202051345 · Cited by 55
“These include autoimmune and autoin-flammatory diseases, such as Aicardi-Goutie`res syndrome (AGS), systemic lupus erythematosus (SLE), and a recently described syndrome caused by DNase II deficiency (Rodero et al , 2017; Hong et al , 2020).”
InfluentialGuo, X., Wiley, C. A., Steinman, R. A., Sheng, Y., Ji, B., Wang, J., Zhang, L., Wang, T., Zenatai, M., Billiar, T. R., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02217-9 · Cited by 53
“Excessive ISG expression is central to AGS as an inflammatory interferonopathy [3, 8, 12].”
BackgroundEbstein, F., Küry, S., Papendorf, J. J., & Krüger, E. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.733012 · Cited by 60
Ginkgetin Alleviates Inflammation and Senescence by Targeting STING
Liu, Y., Ye, J., Fan, Z., Wu, X., Zhang, Y., Yang, R., Jiang, B., Wang, Y., Wu, M., Zhou, J., et al. (2024) · Advanced Science · doi:10.1002/advs.202407222 · Cited by 83
Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects
Soni, C., & Reizis, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01601 · Cited by 58
“Genetic autosomal recessive mutations in RNA processing enzymes of the RNASEH2 complex, ADAR1, and SAMHD1 cause abnormal induction of type-I IFNs and lead to AicardiGoutières syndrome (AGS) and related interferonopathies.”
BackgroundInfluentialMonogenic Autoinflammatory Diseases: State of the Art and Future Perspectives
Donato, G. D., d’Angelo, D. M., Breda, L., & Chiarelli, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126360 · Cited by 56
Innate virus-sensing pathways in B cell systemic autoimmunity
Vinuesa, C. G., Grenov, A., & Kassiotis, G. (2023) · Science · doi:10.1126/science.adg6427 · Cited by 56
NBS1 is required for macrophage homeostasis and functional activity in mice
Pereira‐Lopes, S., Tur, J., Calatayud-Subias, J. A., Lloberas, J., Stracker, T. H., & Celada, A. (2015) · Blood · doi:10.1182/blood-2015-04-637371 · Cited by 53
Immune Profiling and Precision Medicine in Systemic Lupus Erythematosus
Nagafuchi, Y., Shoda, H., & Fujio, K. (2019) · Cells · doi:10.3390/cells8020140 · Cited by 52
“AGS is now considered as a ‘type I interferonopathy’ because type I IFN production is constitutively upregulated in AGS patients and is directly relevant to pathogenesis [32].”
BackgroundGedik, K. C., Lamot, L., Romano, M., Demirkaya, E., Piskin, D., Torreggiani, S., Adang, L. A., Armangué, T., Barchus, K., Cordova, D., et al. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42087 · Cited by 56
Self-citationLupus eritematoso sistémico: ¿es una sola enfermedad?
Rivas‐Larrauri, F., & Yamazaki‐Nakashimada, M. A. (2016) · Reumatología Clínica · doi:10.1016/j.reuma.2016.01.005 · Cited by 50
RNA sensor LGP2 inhibits TRAF ubiquitin ligase to negatively regulate innate immune signaling
Parisien, J.-P., Lenoir, J. J., Mandhana, R., Rodriguez, K. R., Qian, K., Bruns, A. M., & Horvath, C. M. (2018) · EMBO Reports · doi:10.15252/embr.201745176 · Cited by 52
Mathavarajah, S., & Dellaire, G. (2023) · Biochemistry and Cell Biology · doi:10.1139/bcb-2023-0134 · Cited by 55
Cellular and molecular mechanisms of immune dysregulation and autoimmunity
Azizi, G., Rastegari‐Pouyani, M., Abolhassani, H., Sharifi, L., Zaki‐Dizaji, M., Mohammadi, J., Mirshafiey, A., & Aghamohammadi, A. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.08.012 · Cited by 51
Simon, R. P., Winter, M., Kleiner, C., Ries, R., Schnapp, G., Heimann, A. C., Li, J., Žuvela-Jelaska, L., Bretschneider, T., Luippold, A. H., et al. (2019) · SLAS DISCOVERY · doi:10.1177/2472555219880185 · Cited by 50
Primary immunodeficiencies suggest redundancy within the human immune system
Fischer, A., & Rausell, A. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah5861 · Cited by 51
“The prevalence of GOF mutations in innate immunity genes in known autoinflammatory syndromes (n = 13) suggests that these numbers may be even higher (28, 38).”
BackgroundDuncan, C. J. A., & Hambleton, S. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01118-z · Cited by 50
Novelli, G., Spitalieri, P., Murdocca, M., Centanini, E., & Sangiuolo, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059579 · Cited by 43
“For example, the mutation of the TREX1 gene causes Aicardi Goutieres Syndrome (AGS) type I, which is characterized by dramatic neuronal loss and leads to lifelong disability (Crow and Manel, 2015).”
BackgroundRegulation and function of the cGAS-MITA/STING axis in health and disease
Zhang, Z.-D., & Zhong, B. (2022) · Cell Insight · doi:10.1016/j.cellin.2021.100001 · Cited by 45
RIG-I-like receptors: Molecular mechanism of activation and signaling
Zheng, J., Shi, W., Yang, Z., Chen, J., Qi, A., Yang, Y., Deng, Y., Yang, D., Song, N., Song, B., et al. (2023) · Advances in immunology · doi:10.1016/bs.ai.2023.03.001 · Cited by 57
Xu, H., Wedn, A. M., Wang, J., Gu, Y., Liu, H., Zhang, J., Lin, Z., Zhou, R., Pang, X., & Cui, Y. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107063 · Cited by 51
Oh, C., Ryoo, J., Park, K., Kim, B., Daly, M. B., Cho, D.-Y., & Ahn, K. (2018) · Scientific Reports · doi:10.1038/s41598-017-18308-8 · Cited by 50
Astrocytes, an active player in Aicardi–Goutières syndrome
Sase, S., Takanohashi, A., Vanderver, A., & Almad, A. (2018) · Brain Pathology · doi:10.1111/bpa.12600 · Cited by 45
“Biallelic mutations in RNASEH2A, RNASEH2B and RNASEH2C result in partial loss-of-function in AGS, which accounts for over half of all AGS cases (16, 63).”
BackgroundInfluentialInterferons reshape the 3D conformation and accessibility of macrophage chromatin
Platanitis, E., Gruener, S., Geetha, A. R. S. J., Boccuni, L., Vogt, A., Novatchkova, M., Sommer, A., Barozzi, I., Müller, M. M., & Decker, T. (2022) · iScience · doi:10.1016/j.isci.2022.103840 · Cited by 49
“Additionally, such insight will improve our understanding of the molecular hallmarks of interferon-associated diseases (Crow and Manel, 2015; Sancho-Shimizu et al., 2011).”
BackgroundIntratumoral TREX1 Induction Promotes Immune Evasion by Limiting Type I IFN
Toufektchan, E., Dananberg, A., Striepen, J., Hickling, J. H., Shim, A., Chen, Y., Nichols, A., Paez, M. A. D., Mohr, L., Bakhoum, S. F., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-1093 · Cited by 49
ER: a critical hub for STING signaling regulation
Luo, Y., Chang, L., Ji, Y., & Liang, T. (2024) · Trends in Cell Biology · doi:10.1016/j.tcb.2024.02.006 · Cited by 47
STING signals to NF-κB from late endolysosomal compartments using IRF3 as an adaptor
Zhang, B., Pedersen, A., Reinert, L. S., Li, Y., Narita, R., Idorn, M., Hu, L., Skouboe, M. K., Li, S., Maimaitili, M., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02283-8 · Cited by 55
“Moreover, the brains of higher organisms are very sensitive to inflammatory activities, including STING-driven inflammatory responses 52 .”
Banuelos‐Sanchez, G., Sánchez, L., Benitez‐Guijarro, M., Sanchez-Carnerero, V., Salvador‐Palomeque, C., Tristán-Ramos, P., Benkaddour-Boumzaouad, M., Morell, S., García-Puche, J. L., Heras, S. R., et al. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.04.010 · Cited by 50
Inflammatory signaling in genomically instable cancers
Talens, F., & van Vugt, M. A. T. M. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1638192 · Cited by 43
“Specifically, mutations in genes encoding RNase H2 subunits lead to the autoimmune disorder Aicardi-Goutières syndrome (AGS),which is characterized by increasedproduction of type-I IFN [91,92].”
BackgroundSTAT1 modulates tissue wasting or overgrowth downstream from PDGFRβ
He, C., Medley, S. C., Kim, J. H., Sun, C., Kwon, H. R., Sakashita, H., Pincu, Y., Yao, L., Eppard, D., Dai, B., et al. (2017) · Genes & Development · doi:10.1101/gad.300384.117 · Cited by 42
Role of Mitochondrial Nucleic Acid Sensing Pathways in Health and Patho-Physiology
Chowdhury, A., Witte, S., & Aich, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.796066 · Cited by 43
Mutant RIG-I enhances cancer-related inflammation through activation of circRIG-I signaling
Song, J., Zhao, W., Zhang, X., Tian, W., Zhao, X., Ma, L., Cao, Y., Yin, Y., Zhang, X., Deng, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34885-3 · Cited by 45
Manjunath, L., Oh, S., Ortega, P., Bouin, A., Bournique, E., Sanchez, A., Martensen, P. M., Auerbach, A. A., Becker, J. T., Seldin, M. M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36445-9 · Cited by 44
cGAS-STING DNA-sensing in inflammatory bowel diseases
Dimitrov, G., Ryffel, B., Togbe, D., & Quesniaux, V. F. J. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2024.10.002 · Cited by 45
Frans, G., Moens, L., Schaballie, H., Wuyts, G., Liston, A., Poesen, K., Janssens, A. M., Rice, G., Crow, Y. J., Meyts, I., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.050 · Cited by 42
Self-citationAbsent in Melanoma 2 proteins in SLE
Choubey, D., & Panchanathan, R. (2017) · Clinical Immunology · doi:10.1016/j.clim.2016.12.011 · Cited by 42
Persistent RNA virus infections: do PAMPS drive chronic disease?
McCarthy, M. K., & Morrison, T. E. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.01.003 · Cited by 42
Combination and inducible adjuvants targeting nucleic acid sensors
Temizoz, B., Kuroda, E., & Ishii, K. J. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.05.003 · Cited by 41
Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
Hiller, B., Hoppe, A., Haase, C., Hiller, C., Schubert, N., Müller, W., Reijns, M. A. M., Jackson, A. P., Kunkel, T. A., Wenzel, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1099 · Cited by 43
“autoimmune disorder Aicardi-Goutières syndrome (AGS), which can be caused by partial loss of function of RNase H2 or by mutations in other enzymes involved in nucleic acid metabolism [27, 28].”
Kienes, I., Weidl, T., Mirza, N., Chamaillard, M., & Kufer, T. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031301 · Cited by 46
“The generic term of ‘type I interferonopathy’ has been conceptualized based on clinical evidence of biological similarities between the sickness behaviors of several autoinflammatory conditions with a constitutive upregulation of type I IFN production, including Aicardi-Goutières syndrome [281,282].”
BackgroundChasset, F., Dayer, J., & Chizzolini, C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633821 · Cited by 46
“Further interest in IFN and SADs has spurred form the recent identification of monogenic disorders named interferonopathies characterized by high IFN production and clinical manifestations partly resembling those of SADs (Crow and Manel, 2015).”
BackgroundCarter, V., LaCava, J., Taylor, M. S., Liang, S. Y., Mustelin, C., Ukadike, K. C., Bengtsson, A., Lood, C., & Mustelin, T. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41054 · Cited by 41
“known as AicardiGoutières syndrome (15,16), which is charac-”
BackgroundTransposable elements and their role in aging
Yushkova, E., & Moskalev, A. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101881 · Cited by 41
cGAS Mediates Inflammation by Polarizing Macrophages to M1 Phenotype via the mTORC1 Pathway
Shen, X., Sun, C., Cheng, Y., Ma, D., Sun, Y.-L., Lin, Y., Zhao, Y., Yang, M., Jing, W., Cui, X., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2200351 · Cited by 43
Seamon, K. J., Bumpus, N. N., & Stivers, J. T. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00986 · Cited by 42
Does type-I interferon drive systemic autoimmunity?
Picard, C., & Bélot, A. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.07.001 · Cited by 43
DNA as a self-antigen: nature and regulation
Soni, C., & Reizis, B. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.09.009 · Cited by 47
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.